New Jersey Heart — Linden, New Jersey

New Jersey Heart is a clinical research site located in Linden, New Jersey, United States 07036.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

New Jersey Heart has participated in 7 clinical trials with 2 currently active.

Therapeutic areas: Acute Coronary Syndromes, Primary Prevention of Atherosclerotic Cardiovascular Disease, Diabetes Mellitus, Type 2.

Sponsors: Bristol-Myers Squibb, Novartis Pharmaceuticals, Duke University.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Linden

Browse all research sites in New Jersey · View every site in Linden

• NJ Heart
• Research Site
• GSK Investigational Site
• NJ MedCare & NJ Heart
• Pfizer Investigational Site
• Investigator Site 11-054
• Linden Meals on Wheels
• Local Institution - 0334
• Investigational Site Number 8400020
• NJ Heart | Linden, NJ
• Forest Investigative Site 1141

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Jersey Heart?

New Jersey Heart has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Jersey Heart conducted?

New Jersey Heart has 7 clinical trials on record, with 2 currently active. Their work covers Acute Coronary Syndromes, Primary Prevention of Atherosclerotic Cardiovascular Disease, Diabetes Mellitus, Type 2.

Is New Jersey Heart accredited by Crixeo Clinical Trials?

New Jersey Heart has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New Jersey Heart?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.